Table 3.
Goodness-of-Fit Statistics
| Volume of interest | Patients |
Control subjects |
||
|---|---|---|---|---|
| No. | Results | No. | Results | |
| mI/Cr, hypothalamus | 13 | 15.7 ± 1.2 | 11 | 15.5 ± 0.6 |
| (total NAA)/Cr, hypothalamus | 14 | 16.3 ± 1.2 | 12 | 15.2 ± 0.9 |
| mI/Cr, pontomesencephalic junction | 13 | 11.8 ± 1.1 | 14 | 13.4 ± 1.5 |
| (total NAA)/Cr, pontomesencephalic junction | 14 | 7.9 ± 0.6 | 14 | 7.4 ± 0.4 |
| mI/Cr, right amygdala | 10 | 20.1 ± 2.0 | 13 | 14.7 ± 1.2 |
| (total NAA)/Cr, right amygdala | 12 | 13.7 ± 1.2 | 13 | 11.8 ± 0.5 |
| mI/Cr, left amygdala | 12 | 16.2 ± 1.4 | 12 | 16.8 ± 1.7 |
| (total NAA)/Cr, left amygdala | 13 | 12.8 ± 1.3 | 14 | 12.0 ± 1.0 |
Data are presented as mean ± SEM.
NAA refers to N-acetylaspartate;
Cr, creatine;
mI, myoinositol